Dalton Investments’ Return, AUM, and Holdings

Page 2 of 2

The second most valuable position in Dalton Investment’s portfolio at the end of Q3 2018, was the one in Genpact Limited (NYSE:G). It included 750,619 shares, with a value of $22.98 million. The biggest new stake the fund made during the third quarter was in Cheniere Energy, Inc. (NYSEAMERICAN:LNG), an energy company that mainly provides liquefied natural gas-related services. The company has a market cap of $16.83 billion, and over the past six months, its stock gained 2.37%, currently trading at $65.52. For the three months ended September 30, 2018, Cheniere Energy reported revenues of $1.82 billion, compared to $1.40 billion for the third quarter of 2017. There were 42 hedge funds long the stock at the end of Q3 2018, up by one from the second quarter of 2018.

Dalton Investments initiated the second biggest stake during the third quarter in China Biologic Products Holdings Inc (NASDAQ:CBPO), a large fully integrated plasma-based biopharmaceutical company in China, with a market cap of $3.14 billion. The fund acquired 54,551 China Biologic’s shares outstanding, which were worth $4.36 million. The third new position the fund established in BEST Inc (NYSE:BSTI), a Smart Supply Chain company based in Hangzhou, China. Dalton Investments purchased 152,900 BEST’s shares that were valued $905,000.

The biggest position the fund decided to drop during Q3 2018, was the one in Cheniere Energy Partners LP (NYSEAMERICAN:CQP), and it counted 425,038 shares outstanding with a value of $13.37 million. Dalton Investments also said goodbye to its position in Exela Technologies, Inc. (NASDAQCM:XELA), which included 179,800 shares that were worth $854,000.

Disclosure: None

This article was originally published at Insider Monkey.

 

Page 2 of 2